Joseph Vanderveen DO in Tawas City, Michigan

Home Michigan Tawas City

Joseph Vanderveen DO has Internal Medicine as his primary medical specialty. Their primary office is: 312 W M in Tawas City, Michigan. There are 2 additional office locations for Joseph Vanderveen DO that can be viewed towards the end of their profile.

They're a part of the: Mclaren Central Michigan medical group which has around 183 members. You can call their office at 989-362-9551 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Michigan State University College Of Human Medicine and graduated in 1992 (around 32 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Joseph J Vanderveen DO Office Phone and Directions

Joseph Vanderveen DO
Mclaren Central Michigan
312 W M
Tawas City, Michigan 48763
989-362-9551

Patient Ratings
Please rate your experience with Joseph Vanderveen DO below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 989-362-9551

Enter a starting address:

Healthcare Info for Joseph Vanderveen DO

Medical School: Michigan State University College Of Human Medicine
Graduation Year: 1992
The Primary Medical Specialty for Joseph Vanderveen DO is listed as: Internal Medicine
Credentials: DO
Additional Credentials:
Approximate Years of Experience: 32
PAC (PECOS ID)#: 5496765604
NPI #: 1104869171
NPI Created On: 06/14/2006
NPI Last Updated Listed as: 07/17/2008
Primary Taxonomy Code: 207R00000X
License Number:
5101011670
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
McLaren Health Plan Community
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Urine microalbumin (protein) analysis
Hemoglobin a1c level
Vaccine for influenza for injection into muscle
Vaccine for influenza for administration into muscle, 0.5 ml dosage
Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Measurement of lung diffusing capacity
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge
Administration of influenza virus vaccine
Administration of pneumococcal vaccine
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $80

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Educational Program

Record ID:: 829663719

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30